SMAC exhibits anti-tumor effects in ECA109 cells by regulating expression of inhibitor of apoptosis protein family

Figure 2 Proliferation of ECA109 cells in the control group and treatment groups with different concentration of LCL161. Proliferation of ECA109 cells decreased in the 5 mmol/L, 10 mmol/L, and 20 mmol/L groups compared to the control group (P < 0.05) at different time points (24 h, 48 h, and 72 h). A: Control group; B: 5 mmol/L LCL161 treatment group; C: 10 mmol/L LCL161 treatment group; D: 20 mmol/L LCL161 treatment group.